Hebei Yiling Medical Research Institute

Hebei Yiling Medical Research Institute is the core R&D subsidiary of Yiling Pharmaceutical focused on the discovery and translational development of traditional Chinese medicine, chemical drugs, biologics, and health products. The institute is built around Yiling's collateral disease theory and a vertically integrated model spanning theory, clinical research, laboratory studies, drug discovery, and evidence generation. It has supported the development of multiple marketed Chinese medicines including Lianhua Qingwen, Tongxinluo, Shensong Yangxin, Qili Qiangxin, Jinlida, Jiyu Chufan, and Bazi Bushen, while also advancing chemical-drug programs into clinical development. The organization operates major national-level research platforms in Shijiazhuang and serves as the principal scientific engine behind Yiling Pharmaceutical's pipeline and lifecycle management.